Aug 2026· Journal of Affective Disorders· Vol 414, pp.
122347
· 0 citations· 63 references
Medicine
TL;DR
It is suggested that non-remission is characterized by reduced functional integration with relatively preserved structural connectivity, while remission is associated with preserved functional organization but lower baseline structural efficiency.
Abstract
INTRODUCTION
Electroconvulsive therapy (ECT) is the most effective intervention for depression, yet no validated biomarkers reliably predict which patients will remit. Large-scale structural and functional dysconnectivity is well-established in major depressive disorder, motivating the use of graph-theoretical metrics to capture network architecture and identify treatment-sensitive markers.
Methods
In a prospective longitudinal study, 41 adult patients with a major depressive episode undergoing ECT and 24 healthy controls underwent anatomical, diffusion and resting-state functional MRI at baseline (V1). Patients were reassessed after five ECT sessions (V2, n = 31) and two weeks following treatment completion (V3, n = 29). Structural networks were constructed from multi-shell diffusion tractography and functional networks from rs-fMRI. Longitudinal change of global and local efficiency was assessed using linear mixed-effects models, and baseline predictors of remission (MADRS ≤10 at V3) were evaluated using ANOVAs and penalized binomial regression.
Results
Graph-theory metrics remained stable across timepoints, indicating no large-scale network reorganization during ECT. At baseline, patients showed reduced structural local efficiency relative to controls. Future remitters exhibited lower structural local and global efficiency in fractional anisotropy and neurite density index (NDI)-weighted networks at baseline compared with non-remitters, whereas non-remitters showed reduced functional local efficiency at baseline relative to controls. Penalized regression identified baseline NDI-weighted global efficiency as a significant predictor of remission.
Conclusion
Baseline structural and functional network profiles distinguished ECT remitters from non-remitters. These findings suggest that non-remission is characterized by reduced functional integration with relatively preserved structural connectivity, while remission is associated with preserved functional organization but lower baseline structural efficiency.
Abstract Electroconvulsive therapy (ECT) is the most effective treatment for severe or intractable depression. The disrupt–potentiate–rewire framework proposes that ECT’s therapeutic effects include neural remodeling. We used the neurite orientation dispersion and density imaging (NODDI) model to characterize ECT-relat...
A. Zavaliangos-Petropulu, Paloma Pfeiffer, Madeline Crawford et al.· Research Square· 0 citations
Variability in electroconvulsive therapy (ECT) response among patients with schizophrenia and the risks of ineffective treatment limit its clinical use. Identifying reliable predictors to accurately forecast patient response to ECT continues to be a major challenge. This study aimed to investigate whether insula-...
Ya-Peng Cui, Ruoxi Yun, Xue Li et al.· BMC Psychiatry· 0 citations
Major depressive disorder (MDD) is highly prevalent, yet antidepressant selection remains largely trial and error because of limited predictive biomarkers. Resting-state electroencephalography (EEG) combined with graph theory-based functional networks offers a noninvasive approach to probing brain dysconnectivity. This...
Young Wook Song, Hyeon-Ah Lee, Sungkean Kim et al.· Progress in Neuro-psychophar...· 0 citations
Abstract Background Treatment-resistant depression (TRD) represents a severe subtype of major depressive disorder (MDD) characterized by inadequate response to antidepressant treatments. Although large-scale network (e.g., default mode network) dysfunction, has been implicated in MDD, the structural network substrates...
C.-T. Li, Y.-Z. Lee, C.-W. Hsu et al.· International Journal of Neu...· 0 citations
To examine whether pretreatment resting-state functional connectivity (rsFC) of hippocampal subregions is associated with 12-week escitalopram treatment outcomes in major depressive disorder (MDD).
A total of 87 patients with MDD received 12 weeks of escitalopram monotherapy and underwent resting-state funct...
Feng-Xia Zhang, Xiao-Ya Li, Ling Zhang et al.· Frontiers in Psychiatry· 0 citations
This research deepens the understanding of the biological diversity of MDD, providing a biologically grounded framework for stratifying patients, which may inform the future design of hypothesis‐driven clinical trials targeting specific cognitive or sensorimotor circuits.
Xiao-Zheng Liu, Zhong-Wei Guo· Depression and Anxiety· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.